EP3999070A4 - Composition de comprimé effervescent de sitagliptine - Google Patents

Composition de comprimé effervescent de sitagliptine Download PDF

Info

Publication number
EP3999070A4
EP3999070A4 EP20841192.6A EP20841192A EP3999070A4 EP 3999070 A4 EP3999070 A4 EP 3999070A4 EP 20841192 A EP20841192 A EP 20841192A EP 3999070 A4 EP3999070 A4 EP 3999070A4
Authority
EP
European Patent Office
Prior art keywords
sitagliptin
effervescent tablet
tablet composition
composition
effervescent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP20841192.6A
Other languages
German (de)
English (en)
Other versions
EP3999070A1 (fr
Inventor
Seval Ataman
Muge ULUSOY BOZYEL
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanovel Ilac Sanayi ve Ticaret AS
Original Assignee
Sanovel Ilac Sanayi ve Ticaret AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi ve Ticaret AS filed Critical Sanovel Ilac Sanayi ve Ticaret AS
Publication of EP3999070A1 publication Critical patent/EP3999070A1/fr
Publication of EP3999070A4 publication Critical patent/EP3999070A4/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
EP20841192.6A 2019-07-17 2020-07-10 Composition de comprimé effervescent de sitagliptine Pending EP3999070A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2019/10633A TR201910633A1 (tr) 2019-07-17 2019-07-17 Si̇taglipti̇n i̇çeren efervesan tablet kompozi̇syonu
PCT/TR2020/050615 WO2021010924A1 (fr) 2019-07-17 2020-07-10 Composition de comprimé effervescent de sitagliptine

Publications (2)

Publication Number Publication Date
EP3999070A1 EP3999070A1 (fr) 2022-05-25
EP3999070A4 true EP3999070A4 (fr) 2023-08-16

Family

ID=74209853

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20841192.6A Pending EP3999070A4 (fr) 2019-07-17 2020-07-10 Composition de comprimé effervescent de sitagliptine

Country Status (3)

Country Link
EP (1) EP3999070A4 (fr)
TR (1) TR201910633A1 (fr)
WO (1) WO2021010924A1 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010000469A2 (fr) * 2008-07-03 2010-01-07 Ratiopharm Gmbh Sels cristallins de sitagliptine
US20160367552A1 (en) * 2014-02-25 2016-12-22 Cadila Healthcare Limited Pharmaceutical compositions of sitagliptin
US20180360737A1 (en) * 2015-12-12 2018-12-20 Steerlife India Private Limited Effervescent compositions of metformin and processes for preparation thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013077819A1 (fr) * 2011-11-23 2013-05-30 Mahmut Bilgic Préparations pharmaceutiques comprenant du natéglinide
WO2013115744A1 (fr) * 2012-01-31 2013-08-08 Mahmut Bilgic Procédé de préparation de compositions pharmaceutiques (effervescentes) contenant un inhibiteur de l'apha-glucosidase (p. ex. voglibose et metformine)

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010000469A2 (fr) * 2008-07-03 2010-01-07 Ratiopharm Gmbh Sels cristallins de sitagliptine
US20160367552A1 (en) * 2014-02-25 2016-12-22 Cadila Healthcare Limited Pharmaceutical compositions of sitagliptin
US20180360737A1 (en) * 2015-12-12 2018-12-20 Steerlife India Private Limited Effervescent compositions of metformin and processes for preparation thereof

Also Published As

Publication number Publication date
TR201910633A1 (tr) 2021-05-21
WO2021010924A1 (fr) 2021-01-21
EP3999070A1 (fr) 2022-05-25

Similar Documents

Publication Publication Date Title
EP3914252A4 (fr) Composition pharmaceutique du nilotinib
EP3849983A4 (fr) Composés de triazolo-pyrimidine et leurs utilisations
EP3582777A4 (fr) Composition pharmaceutique d'apixaban
EP3860585A4 (fr) Compositions thérapeutiques
EP3728260A4 (fr) Inhibiteurs spiro exo-aza de l'interaction ménine-mll
EP3851121A4 (fr) Composition pharmaceutique contenant un anticorps monoclonal anti-il-33 humain
EP3781135A4 (fr) Compositoins pharmaceutiques solides d'administration par voie orale comprenant de la sitagliptine
EP3630113A4 (fr) Composition pharmaceutique comprenant un inhibiteur de pde9
EP3927729A4 (fr) Formulation d'anticorps thérapeutique
EP3980005A4 (fr) Formulation de carbachol-brimonidine permettant d'améliorer des effets anti-presbytie
EP3976001A4 (fr) Formulations de comprimés d'aprémilast
EP3917910A4 (fr) Composés et compositions thérapeutiques
EP4077256A4 (fr) Préparation d'un alcoxyéthane halogéné
EP3873444A4 (fr) Composés et compositions thérapeutiques
EP3784672A4 (fr) Formulations de comprimés comprenant de la metformine et de la sitagliptine
EP3972598A4 (fr) Nouvelles utilisations du crénolanib
EP3881841A4 (fr) Composition pharmaceutique
EP3810118A4 (fr) Formulations de tegavivint et composés apparentés
EP3755376A4 (fr) Formulations contenant des protéases affectant la mucine
EP3999070A4 (fr) Composition de comprimé effervescent de sitagliptine
EP3603641A4 (fr) Composition pharmaceutique contenant un inhibiteur de dusp1
EP4005556A4 (fr) Composition pharmaceutique comprenant de l'udénafil
EP3984549A4 (fr) Composition médicinale
EP4034130A4 (fr) Composés pharmaceutiques et procédés d'utilisation
EP3949952A4 (fr) Composition médicinale

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20220114

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20230717

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230708

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 47/00 20060101ALI20230711BHEP

Ipc: A61K 9/20 20060101ALI20230711BHEP

Ipc: A61K 9/46 20060101ALI20230711BHEP

Ipc: A61K 31/4985 20060101AFI20230711BHEP